• The Company
    • Who we are
    • Partner Portal
  • Meet the Partners
  • Our Approach
  • Portfolio
    • Current Portfolio
    • Historic Portfolio
  • News
  • Contact Us
The Vertical Group
Investing for Innovation

Seeking to save billions of dollars, employers turn to Bay Area companies to help with diabetes

5/22/2019

 
Via: Silicon Valley Business Journal 
For diabetic workers, access to a refrigerator and insulin breaks are not a workplace perk. They are potentially a matter of life and death.

Read More: https://www.bizjournals.com/sanjose/news/2019/05/22/disease-management-companies-on-the-rise-omada.html

Stroke-prevention procedure serves as option for high-risk patients

5/19/2019

 
Via: The Carle Foundation
The signs of Robert Nemeth’s mini-stroke were clear.
“I was standing in front of the refrigerator, and my right arm wouldn’t move. I realized something was very wrong,” Nemeth said.
The Sadorus man needed a procedure to help clear his carotid artery, which was 90 percent blocked. Because of previous radiation treatments to his neck, traditional surgery could have been risky.
Thankfully, surgeons at Carle Heart & Vascular Institute perform a minimally invasive procedure to reach the carotid artery through a small incision in the clavicle. Carle is the only Illinois hospital outside the Chicago and St. Louis areas to offer TransCarotid Artery Revascularization (TCAR).
“This is the future,” said Carle vascular surgeon Brian Beeman, MD. “TCAR is a much safer option for patients who are at high risk for traditional surgery, including patients with congestive heart failure and recent heart attack.”

Read More: 
https://newsroom.carle.org/quality-innovation/stroke-prevention-procedure-serves-as-option-for-high-risk-patients.htm

Minimally invasive procedure can reduce stroke risk

5/13/2019

 
Via: Kinston
Gary Sunderland was recovering from a heart procedure at New Hanover Regional Medical Center when a physician assistant stopped by to assess him. Using a stethoscope, the physician assistant listened to the carotid artery in his neck.
She didn’t like what she heard.

He got a referral to a vascular surgeon and discovered he had blockages in his carotid arteries, which carry oxygenated blood to the brain. Carotid artery disease, which happens when plaque clogs the blood vessels, increases the risk of a stroke.
“It was like a ticking time bomb,” said Sunderland, who is 81 and has enjoyed good health all his life.

​The most commonly performed surgery to remedy blocked carotid arteries is a carotid endarterectomy, which involves a surgeon opening the artery to remove the plaque. This procedure is offered at NHRMC, but it is invasive and not ideal for everyone.

After reviewing Sunderland’s case, Dr. Michael Patton, a Wilmington vascular surgeon, recommended a minimally invasive procedure to place stents in his carotid arteries, lowering his risk of stroke. Patton placed the stents, which are small mesh tubes, using the TCAR procedure, which stands for transcarotid artery revascularization.

Read More: https://www.kinston.com/news/20190513/minimally-invasive-procedure-can-reduce-stroke-risk

Stealthy Route 92 Medical raises $13m

5/13/2019

 
Via: MassDevice
Stealthy catheter developer Route 92 Medical, which is developing a catheter to treat stroke, last week said it raised nearly $13 million in an equity round.

Founded in 2015, San Mateo, Calif.-based Route 92 won 510(k) clearance from the FDA a year ago for a percutaneous catheter. The company holds U.S. patents for treating acute ischemic stroke, a rapid aspiration thrombectomy system and intra-cerebral implant delivery.

According to regulatory filings, Route 92 first drummed up $5.9 million in May 2016. Just less than a year later the company doubled that raise, adding another $4.7 million in August 2018. Including the most-recent May 25 filing, Route 92 Medical has raised $29.5 million in equity rounds.

Read More: https://www.massdevice.com/stealthy-route-92-medical-raises-13m/

Silk Road Medical Reports First Quarter 2019 Financial Results

5/8/2019

 
Via: GlobeNewsWire
SUNNYVALE, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2019.

Recent Highlights
  • Recorded revenues of $12.8 million for the first quarter of 2019, representing a 124% increase over the first quarter of 2018
  • Completed initial public offering of six million shares, raising approximately $108.8 million in net proceeds, after deducting underwriting fees and other expenses
  • Completed enrollment in the ROADSTER 2 study
  • Clinical data from the TCAR Surveillance Project to be presented at the Society for Vascular Surgery’s Vascular Annual Meeting in June​​

​“At Silk Road Medical, we are motivated by relentless dedication to successful patient outcomes and by our focus on two key priorities of expanding the clinical evidence and U.S. commercial execution. We are pleased to report first quarter results which reflect these priorities,” said Erica Rogers, Chief Executive Officer. “Commercial momentum is achieved by driving physician adoption of TCAR procedures which recently surpassed 10,000 globally. We are simultaneously progressing forward with clinical evidence and are pleased to announce that we have completed enrollment in our ROADSTER 2 study.”

Read More: 
https://www.globenewswire.com/news-release/2019/05/08/1819696/0/en/Silk-Road-Medical-Reports-First-Quarter-2019-Financial-Results.html

    Archives

    October 2023
    September 2023
    September 2022
    August 2022
    June 2022
    May 2022
    February 2022
    January 2022
    December 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    December 2019
    November 2019
    October 2019
    August 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    April 2015
    March 2015
    February 2015
    January 2015
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    February 2014
    January 2014
    December 2013
    October 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013

    RSS Feed

© The Vertical Group - [email protected]
 PO 218, Berkeley Heights, NJ 07922 | (908) 277-3737
PO 5006, San Mateo, CA  94402 | (650) 566-9060
Picture
Website by Custom Dynamics